LEXINGTON, Mass., April 21, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, […]
Companies to Collaborate on Phase II Development for NV-5138 in DepressionNV-5138 is a Novel First-in-Class Activator of mTORC1Supernus Receives Exclusive […]